Endocrine therapies such as selective estrogen receptor modulators (SERMs), selective estrogen receptor downregulators (SERDs) or aromatase inhibitors are the standard-of-care treatment for this breast cancer subset, and these therapies have significantly reduced mortality and disease recurrence [2]. The gene discussed is ESR1; the disease is breast cancer.